(22375448), G. M., (22375451), F. T., (22375454), D. Q., (22375457), R. S., (18084446), E. R., (22375460), K. H., . . . (18084461), J. R. D. (2025). Table S2 from Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in <i>MYCN</i>-Amplified Cancers.
Chicago-čujuhus (17. p.)(22375448), Giulia Montuori, et al. Table S2 from Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in <i>MYCN</i>-Amplified Cancers. 2025.
MLA-čujuhus (9. p.)(22375448), Giulia Montuori, et al. Table S2 from Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in <i>MYCN</i>-Amplified Cancers. 2025.
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.